B
Bahar Sadeghi-Abdollahi
Researcher at Tehran University of Medical Sciences
Publications - 6
Citations - 1101
Bahar Sadeghi-Abdollahi is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Mental health & Prospective cohort study. The author has an hindex of 5, co-authored 6 publications receiving 878 citations.
Papers
More filters
Journal ArticleDOI
The International Criteria for Behçet's Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria
Fereydoun Davatchi,Samir H. Assaad-Khalil,Kenneth T. Calamia,J. E. Crook,Bahar Sadeghi-Abdollahi,Michael Schirmer,T. Tzellos,Christos C. Zouboulis,M. Akhlagi,A. Al-Dalaan,Z. S. Alekberova,A. A. Ali,A. Altenburg,E. Arromdee,M. Baltaci,M. Bastos,S. Benamour,I. Ben Ghorbel,Ayşe Boyvat,L. Carvalho,WenChieh Chen,E. Ben-Chetrit,Cheyda Chams-Davatchi,J. A. Correia,J. Crespo,Carlos Tadeu dos Santos Dias,Y. Dong,F. Paixão-Duarte,K. Elmuntaser,A. V. Elonakov,J. Graña Gil,Ali Akbar Haghdoost,R. M. Hayani,Habib Houman,A. R. Isayeva,Ahmadreza Jamshidi,Phaedon G. Kaklamanis,Ashok Kumar,Athanassios Kyrgidis,Wafa Madanat,Abdolhadi Nadji,Kenichi Namba,Shigeaki Ohno,I. Olivieri,J. Vaz Patto,Nicolò Pipitone,M. V. De Queiroz,F. Ramos,C. Resende,C. M. Rosa,Carlo Salvarani,M. J. Serra,Farhad Shahram,Hormoz Shams,Khalifa E. Sharquie,M. Sliti-Khanfir,T. Tribolet De Abreu,C. Vasconcelos,Joana Vedes,Bertrand Wechsler,Y. K. Cheng,Zilong Zhang,N. Ziaei +62 more
TL;DR: Behçet's disease (BD) is a chronic, relapsing, inflammatory vascular disease with no pathognomonic test.
Journal ArticleDOI
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
Fereydoun Davatchi,Hormoz Shams,Mozhgan Rezaipoor,Bahar Sadeghi-Abdollahi,Farhad Shahram,Abdolhadi Nadji,Cheyda Chams-Davatchi,Massoomeh Akhlaghi,Tahereh Faezi,Nasim Naderi +9 more
TL;DR: The aim of this study was to evaluate the efficacy of rituximab in patients with ocular lesions, the main morbidity of Behcet's disease.
Journal ArticleDOI
Gender influence on ocular manifestations and their outcome in Behcet’s Disease. A long-term follow-up of up to 20 years
Fereydoun Davatchi,Farhad Shahram,Hormoz Shams,Abdolhadi Nadji,Cheyda Chams-Davatchi,Massoomeh Akhlaghi,Seyedeh Tahereh Faezi,Farima Ashofteh,Bahar Sadeghi-Abdollahi +8 more
TL;DR: It is of general belief that males are prone to more frequent, more severe manifestations, and less favorable outcome in ophthalmological manifestations of Behcet's Disease, and ocular gender is more prone to ocular manifestations in BD.
Journal ArticleDOI
Serum Profiles of Cytokines in Behcet's Disease.
Alireza Sadeghi,Fereydoun Davatchi,Farhad Shahram,Arezoo Karimimoghadam,Majid Alikhani,Aiyoub Pezeshgi,Saeideh Mazloomzadeh,Bahar Sadeghi-Abdollahi,Masoud Asadi-Khiavi +8 more
TL;DR: Analysis of cytokine profiles in Iranian BD cases demonstrates that IL-2 may be one of the main proteins that enroll in the pathophysiology of BD uveitis and may be considered as a new target for refractory disease therapies.
Journal ArticleDOI
The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: A case-control study
Soraya Shadmanfar,Farhad Shahram,Abdolhadi Nadji,Maassoumeh Akhlaghi,Seyedeh Tahereh Faezi,Bahar Sadeghi-Abdollahi,Alireza Faridar,Nima Madanchi,Fereydoun Davatchi +8 more
TL;DR: The aim of this study was to find any possible relationship between plasma homocysteine levels and HLA‐B51.